SCTX NASDAQ
Scribe Therapeutics Inc.
YTD: +26.5%
$18.97
-2.68 (-12.38%)
Pre-Market: $19.67 (+0.70, +3.72%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$307.0M
52W Range—
Volume418,351
Avg Volume0
Beta0.00
Dividend—
Analyst Ratings
No analyst coverage
Company Info
1150 MARINA VILLAGE PARKWAY
Alameda, CA 94501
US
Alameda, CA 94501
US
About Scribe Therapeutics Inc.
Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines. The company engineers proprietary technologies to target the genetic drivers of disease, with an initial focus on atherosclerotic cardiovascular disease (ASCVD), aiming to shift treatment from chronic care to preventative intervention.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| ELI LILLY & Co | 0 | — | 2026-07-23 |